They are flirting with profitability. The launch of the medEviewer is likely what brought Blakeley to our doorstep.
That is supposedly due to happen starting this quarter. I would not be surprised to see capital spending for new product prior to years end, if not for tax purposes alone.
An introduction of suitable customers/partners on top of the current business should raise some eyebrows.
Content protection technology is likely the next patent application process for EDIG. That alone, if involved in some upcoming deals, should add value. We will have to see who, what, when and where of course, but in the event anyone is a branded entity or represents a substantial order, this ``ain`t`` no 9 cent stock.
Techs are beginning to make their way back as attractive buys...some success on the DVAP front along with proprietary content protection technology, and EDIG begins to look like a buy.
But then, you and I knew that, right? lol